<Suppliers Price>

Olomoucine

Names

[ CAS No. ]:
101622-51-9

[ Name ]:
Olomoucine

[Synonym ]:
OLO
olomoucine
2-{[6-(Benzylamino)-9-methyl-9H-purin-2-yl]amino}ethanol
Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
MFCD00189360
Olomoucine,high purity
2-(6-Benzylamino-9-methyl-9H-purin-2-ylamino)-ethanol Olomoucine

Biological Activity

[Description]:

Olomoucine is an ATP competitive inhibitor of CDKs. Olomoucine is a purine (HY-34431) derivative and inhibits CDC2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E (both IC50=7 µM), CDK/p35 kinase (IC50=3 µM) and ERK1/p44 MAP kinase (IC50=25 µM)[1][2].

[Related Catalog]:

Research Areas >> Others
Signaling Pathways >> Cell Cycle/DNA Damage >> CDK

[Target]

cdk2-cyclin A:7 μM (IC50)

cdk2-cyclin E:7 μM (IC50)


[References]

[1]. Vesely, J., Havlicek, J., Strnad, M., et al. Inhibition of cyclin-dependent kinases by purine analogues. European Journal of Biochemistry 224, 771-786 (1994).

[2]. 2.Abraham, R.T., Acquarone, M., Andersen, A., et al. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biology of the Cell 83(2), 105-120 (1995).

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
579.6±60.0 °C at 760 mmHg

[ Melting Point ]:
120-130 °C

[ Molecular Formula ]:
C15H18N6O

[ Molecular Weight ]:
298.343

[ Flash Point ]:
304.3±32.9 °C

[ Exact Mass ]:
298.154205

[ PSA ]:
87.89000

[ LogP ]:
-0.08

[ Vapour Pressure ]:
0.0±1.7 mmHg at 25°C

[ Index of Refraction ]:
1.691

[ Storage condition ]:
−20°C

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Precursor & DownStream

Articles

Inhibition of cyclin-dependent kinases by purine analogues.

Eur. J. Biochem. 224 , 771, (1994)

While testing purines related to the non-specific protein kinase inhibitors N6-dimethylaminopurine and N6-(delta 2-isopentenyl)adenine as potential inhibitors of the p34cdc2/cyclin B kinase, we discov...

Steering neuronal growth cones by shifting the imbalance between exocytosis and endocytosis.

J. Neurosci. 34(21) , 7165-78, (2014)

Extracellular molecular cues guide migrating growth cones along specific routes during development of axon tracts. Such processes rely on asymmetric elevation of cytosolic Ca(2+) concentrations across...

Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.

Biol. Cell 83 , 105-120, (1995)

Olomoucine (2-(2-hydroxyethylamino)-6-benzylamino-9-methylpurine) has been recently described as a competitive inhibitor (ATP-binding site) of the cell cycle regulating p34cdc2/cyclin B, p33cdk2/cycli...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.